Iovance Biotherapeutics, Inc.
US ˙ NasdaqGM ˙ US4622601007

SecurityIOVA / Iovance Biotherapeutics, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership1,916,704 shares
Latest Disclosed Value $ 6,727,631
UBS Group AG ownership in IOVA / Iovance Biotherapeutics, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 1,916,704 shares of Iovance Biotherapeutics, Inc. (US:IOVA) valued at $6,727,631 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 764,154 shares of Iovance Biotherapeutics, Inc.. This represents a change in shares of 150.83% during the quarter. The current value of the position is $8,395,164 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (IOVA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IOVA / Iovance Biotherapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,916,704 1,152,550 150.83 6,728 222.48 0.0010
2026-01-29 2025-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 764,154 -172,350 -18.40 2,086 2.66 0.0003
2025-11-13 2025-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 936,504 -842,908 -47.37 2,032 -33.59 0.0003
2025-08-14 2025-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,779,412 -717,337 -28.73 3,061 -63.19 0.0005
2025-05-13 2025-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 2,496,749 -207,720 -7.68 8,314 -58.46 0.0015
2025-02-14 2024-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 2,704,469 2,082,340 334.71 20,013 242.63 0.0037
2024-11-14 2024-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 622,129 -173,075 -21.76 5,842 -8.41 0.0013
2024-08-14 2024-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 795,204 104,324 15.10 6,378 -37.71 0.0016
2024-05-13 2024-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 690,880 -166,428 -19.41 10,239 46.91 0.0025
2024-02-09 2023-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 857,308 615,920 255.16 6,970 534.70 0.0021
2023-11-09 2023-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 241,388 -228,424 -48.62 1,098 -66.80 0.0004
2023-08-11 2023-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 469,812 42,993 10.07 3,307 26.85 0.0011
2023-05-12 2023-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 426,819 -370,863 -46.49 2,608 -48.85 0.0010
2023-02-08 2022-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 797,682 691,443 650.84 5,097 400.69 0.0019
2022-11-10 2022-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 106,239 11,600 12.26 1,018 -2.58 0.0004
2022-08-10 2022-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 94,639 -265,107 -73.69 1,045 -82.55 0.0004
2022-05-16 2022-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 359,746 140,209 63.87 5,990 42.93 0.0020
2022-02-14 2021-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 219,537 23,253 11.85 4,191 -13.41 0.0012
2021-11-15 2021-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 196,284 133,742 213.84 4,840 197.48 0.0015
2021-08-13 2021-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 62,542 -35,306 -36.08 1,627 -47.47 0.0005
2021-05-12 2021-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 97,848 12,219 14.27 3,097 -22.05 0.0010
2021-02-11 2020-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 85,629 13,650 18.96 3,973 67.64 0.0013
2020-11-12 2020-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 71,979 26,685 58.92 2,370 90.67 0.0009
2020-07-31 2020-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 45,294 17,495 62.93 1,243 49.40 0.0005
2020-05-01 2020-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 27,799 -112,893 -80.24 832 -78.63 0.0004
2020-02-14 2019-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 140,692 -235,229 -62.57 3,894 -43.09 0.0014
2019-11-14 2019-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 375,921 244,162 185.31 6,842 111.83 0.0026
2019-08-14 2019-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 131,759 121,504 1,184.83 3,230 3,195.92 0.0012
2019-05-14 2019-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 10,255 -259,239 -96.19 98 -95.89 0.0000
2019-02-14 2018-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 269,494 223,833 490.21 2,385 364.91 0.0011
2018-11-14 2018-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 45,661 38,276 518.29 513 440.00 0.0002
2018-08-14 2018-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 7,385 -53,837 -87.94 95 -90.82 0.0000
2018-05-15 2018-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 61,222 59,826 4,285.53 1,035 9,309.09 0.0004
2018-02-14 2017-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,396 -6,604 -82.55 11 -82.26 0.0000
2017-11-14 2017-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 8,000 -1,072 -11.82 62 -7.46 0.0000
2017-11-14 2017-06-30 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 9,072 -15,928 -63.71 67 -63.98 0.0000
2017-08-14 2017-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 9,072 67
2017-11-14 2017-03-31 13F/A-1 LION BIOTECHNOLOGIES COM 53619R102 25,000 -137,770 -84.64 186 -83.55 0.0001
2017-05-12 2017-03-31 13F LION BIOTECHNOLOGIES COM 53619R102 25,000 -137,770 186
2017-02-14 2016-12-31 13F LION BIOTECHNOLOGIES COM 53619R102 162,770 -130,238 -44.45 1,131 -53.11 0.0006
2016-11-14 2016-09-30 13F LION BIOTECHNOLOGIES COM 53619R102 293,008 14,302 5.13 2,412 6.87 0.0014
2016-08-12 2016-06-30 13F LION BIOTECHNOLOGIES COM 53619R102 278,706 1,991 0.72 2,257 60.53 0.0014
2016-05-12 2016-03-31 13F LION BIOTECHNOLOGIES COM 53619R102 276,715 -24,604 -8.17 1,406 -39.55 0.0009
2016-02-16 2015-12-31 13F LION BIOTECHNOLOGIES COM 53619R102 301,319 -56,681 -15.83 2,326 12.80 0.0015
2015-11-13 2015-09-30 13F LION BIOTECHNOLOGIES COM 53619R102 358,000 37,900 11.84 2,062 -29.74 0.0015
2015-08-14 2015-06-30 13F LION BIOTECHNOLOGIES COM 53619R102 320,100 116,600 57.30 2,935 19.12 0.0020
2015-05-14 2015-03-31 13F LION BIOTECHNOLOGIES COM 53619R102 203,500 203,500 2,464 0.0017
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-05-01 2020-03-31 13F IOVANCE BIOTHERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F IOVANCE BIOTHERAPEUTICS COM Call 15,000 415 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.